The Syndrome of Thrombosis, Thrombocytopenia, and Recurrent Spontaneous Abortions Associated with Antiphospholipid Antibodies: Hughes Syndrome

aPL-associated thrombosis (Hughes syndrome) is widely recognized as a major cause of organ damage in autoimmune diseases. Beginning with the first symposium in 1984, international aPL symposia have facilitated research on aPL antibodies, and the clinical standardization of aPL tests. It is hoped that the present symposium will continue this tradition, because much remains to be learnt about the origin and pathogenicity of aPL antibodies. In addition, new insights are needed for more effective therapies to be developed.

[1]  L. Espinoza,et al.  Induction of Experimental Antiphospholipid Antibody Syndrome in PL/J Mice Following Immunization With β2GPI , 1997, American journal of reproductive immunology.

[2]  J. Barker,et al.  Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. , 1996, Circulation.

[3]  Y. Shoenfeld,et al.  Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. , 1994, Journal of autoimmunity.

[4]  K. Elkon,et al.  Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). , 1992, The Journal of clinical investigation.

[5]  E. Harris,et al.  Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. , 1990, American journal of clinical pathology.

[6]  T. Koike,et al.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.

[7]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[8]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Hughes,et al.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. , 1987, Clinical and experimental immunology.

[10]  G. Hughes,et al.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity. , 1987, Annals of the rheumatic diseases.

[11]  C. Mackworth-Young,et al.  ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1983, The Lancet.

[12]  G. Hughes.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. , 1983, British medical journal.

[13]  I. Nilsson,et al.  Intrauterine death and circulating anticoagulant ("antithromboplastin"). , 2009, Acta medica Scandinavica.

[14]  E. Bowie,et al.  THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. , 1963, The Journal of laboratory and clinical medicine.

[15]  C. Mohr,et al.  Biologically false positive serologic tests for syphilis; type, incidence, and cause. , 1952 .